From: First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma
Variable | Groups | Median overall survival in months (95% confidence interval) | Statistical significance, p |
---|---|---|---|
Sex | male | 5.4 (3.1 – 7.7) | 0.2 |
female | 6.3 (3.5 – 9.1) | ||
Age | <75 years | 6.5 (4.6 – 8.4) | 0.3 |
>75 years | 5.3 (3.9 – 6.6) | ||
LDH | normal | 7.1 (4.6 – 9.7) | 0.3 |
high | 5.4 (3.5 – 7.3) | ||
Lymphocytes | normal | 7.8 (5.9 – 9.5) | 0.003* |
low | 3.7 (1.8 - 5.6) | ||
Sodium | normal | 5.8 (4.4 – 7.2) | 0.8 |
low | 8.2 (4.2 – 12.3) | ||
Albumin | normal | 7.7 (4.9 – 10.5) | 0.003* |
low | 3.1 (0.9 – 5.1) | ||
Haemoglobin | normal | 8.1 (5.7 – 10.5) | 0.02* |
5.3 (3.7 – 6.9) | |||
Grade | low | 6.0 (4.5 – 7.6) | 0.9 |
intermediate | 7.5 (6.8 – 8.1) | ||
high | 6.3 (4.8 – 7.9) | ||
Histological subtype | leiomyosarcoma | 10.1 (3.9 – 16.4) | 0.02* |
angiosarcoma | 9.7 (6.4 – 12.9) | ||
undifferentiated | 3.7 (1.2 – 6.2) | ||
other | 5.1 (2.9 – 7.2) | ||
Sites of visceral involvement | Lungs | 5.7 (4.5 – 7.1) | 0.2 |
Liver | 10.1 (0 – 30.9) | ||
bone | 6.3 (0.9 – 11.7) | ||
Age Adjusted Charlson Index | <3 | 9.6 (4.4 – 14.9) | 0.03* |
>3 | 5.6 (3.8 – 7.4) |